Marisa Taylor is a senior correspondent on the KHN enterprise team. She investigates end-of-life care and acute medical care, among other health care topics.
Marisa Taylor
From this contributor
Immigrant children detained in U.S. may struggle to get health care
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
3 July 2018 | 5 min read
Thousands of children younger than 13 detained under U.S. border policy
The Trump administration has detained 2,322 children 12 years old or younger amid its border crackdown.
Thousands of children younger than 13 detained under U.S. border policy
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
22 June 2018 | 6 min read
Federal limits on medical marijuana research hinder treatments
By the time Ann Marie Owen turned to marijuana to treat her pain, she was struggling to walk and talk. She also hallucinated.
Federal limits on medical marijuana research hinder treatments
By
Melissa Bailey, Marisa Taylor, Kaiser Health News
16 April 2018 | 9 min read
Trading controversy dogs health secretary nominee Tom Price
U.S. Health and Human Services secretary nominee Tom Price showed little restraint in his personal stock trading, despite the fact that a House committee he was on was under investigation.
Trading controversy dogs health secretary nominee Tom Price
By
Marisa Taylor, Christina Jewett, Kaiser Health News
9 February 2017 | 7 min read
Explore more from The Transmitter
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
By
Holly Barker
8 July 2026 | 5 min read